A full 83% of the subjects in the first completed pilot study of MDMA-assisted psychotherapy no longer qualified for PTSD after just two sessions (compared to 25% in the placebo group). These subjects, mostly female survivors of sexual assault and also a few veterans, had all tried other treatments. They had suffered for an average of 19 years.